ACTL6A, CHD2, and ACTB had the highest pan‐cancer G‐score for amplification, whereas CHD5, SHPRH, INO80, and ACTR8 had the highest pan‐cancer G‐score for deletions (Figure S1A and Table S3). Here, ACTB is linked to cancer.